Tin tức & Cập nhật
Lọc theo Chuyên ngành:
![[MK TEST DO NOT TOUCH] Annual flu jab in HF patients may lower hospitalization, pneumonia risk](https://sitmspst.blob.core.windows.net/images/articles/annual-flu-jab-in-hf-patients-may-lower-hospitalization-pneumonia-risk-aa0e7a54-a875-4ec5-902d-8a9ffc5305ac-square.jpg)
[MK TEST DO NOT TOUCH] Annual flu jab in HF patients may lower hospitalization, pneumonia risk
An annual influenza vaccination does not lower the risk of cardiovascular (CV) outcomes in patients with heart failure (HF), though it may reduce the risk of pneumonia and hospitalization, according to results of the IVVE study presented at ACC.22.
[MK TEST DO NOT TOUCH] Annual flu jab in HF patients may lower hospitalization, pneumonia risk
27 Apr 2022
![[MK TEST DO NOT TOUCH] Novel drug helps optimize HFrEF therapy](https://sitmspst.blob.core.windows.net/images/articles/acc222diamond-5933e452-f96d-4c51-8721-e4182dd69552-square.jpg)
[MK TEST DO NOT TOUCH] Novel drug helps optimize HFrEF therapy
In individuals receiving renin-angiotensin-aldosterone system inhibitor (RAASi) therapy for heart failure with reduced ejection fraction (HFrEF), the novel potassium binder patiromer effectively reduced serum potassium levels, the DIAMOND trial suggests, thus optimizing a guideline-directed RAASi therapy for these patients.
[MK TEST DO NOT TOUCH] Novel drug helps optimize HFrEF therapy
27 Apr 2022
Does metoprolol influence exercise haemodynamics in HCM?
Exercise contributes to an abnormal risk in pulmonary capillary wedge pressure (PCWP), but is not affected by metoprolol, in patients with obstructive hypertrophic cardiomyopathy (HCM), results of a study have shown.
